DAFNA Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

DAFNA Capital Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,100,000	Closed	-$957K	–	80
2023 Q2	$957K	Hold	1,100,000	–	–	0.26%	54
2023 Q1	$769K	Buy	1,100,000 +317,000	+40%	+$257K	0.23%	53
2022 Q4	$642K	Sell	783,000 -317,000	-29%	-$313K	0.18%	59
2022 Q3	$1.14M	Hold	1,100,000	–	–	0.31%	52
2022 Q2	$1.8M	Buy	1,100,000 +420,000	+62%	+$872K	0.49%	50
2022 Q1	$2M	Buy	680,000 +365,000	+116%	+$1.28M	0.52%	48
2021 Q4	$1.51M	Buy	+315,000	New	+$2.03M	0.38%	53

DAFNA Capital Management's SURF Position: Q3 2023 in Review

DAFNA Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 1,100,000 shares — an estimated $957K sold.

DAFNA Capital Management first reported a position in SURF in Q4 2021 and held it in 7 quarters. The position peaked at $2M in Q1 2022. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

DAFNA Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
DAFNA Capital Management sold 1,100,000 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $957K.
DAFNA Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
DAFNA Capital Management's Surface Oncology, Inc. Common Stock position peaked at $2M in Q1 2022.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on DAFNA Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.